From: Survival analysis of age-related oral squamous cell carcinoma: a population study based on SEER
Clinicopathological variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
SHR (95%CI) | P | SHR (95%CI) | P | |
Age at diagnosis | ||||
18–39 | Reference | Reference | ||
40–49 | 1.04 (0.91–1.18) | 0.590 | 0.98 (0.86–1.12) | 0.800 |
50–59 | 1.17 (1.04–1.32) | 0.011 | 1.06 (0.94–1.20) | 0.360 |
60–69 | 1.37 (1.21–1.55) | < 0.001 | 1.21 (1.07–1.38) | 0.002 |
70 + | 2.05 (1.82–2.32) | < 0.001 | 1.85 (1.63–2.10) | < 0.001 |
Sex | ||||
Female | Reference | Reference | ||
Male | 0.84 (0.81–0.88) | < 0.001 | 0.85 (0.81–0.89) | < 0.001 |
Marital status | ||||
Married | Reference | Reference | ||
Unmarried | 1.71 (1.65–1.78) | < 0.001 | 1.33 (1.27–1.38) | < 0.001 |
Race | ||||
White | Reference | Reference | ||
Black | 1.86 (1.76–1.97) | < 0.001 | 1.29 (1.20–1.38) | < 0.001 |
Asian or Pacific Islander | 1.08 (0.99–1.18) | 0.072 | 1.18 (1.08–1.29) | < 0.001 |
American Indian/Alaska Native | 1.11 (0.86–1.42) | 0.430 | 1.06 (0.82–1.36) | 0.650 |
Location | ||||
Floor of mouth | Reference | Reference | ||
Other mouth | 0.64 (0.60–0.69) | < 0.001 | 0.60 (0.55–0.64) | < 0.001 |
Tongue | 0.72 (0.68–0.77) | < 0.001 | 0.76 (0.71–0.82) | < 0.001 |
Size | ||||
< 1 | Reference | Reference | ||
< 2 | 1.65 (1.45–1.88) | < 0.001 | 1.51 (1.33–1.72) | < 0.001 |
< 3 | 2.49 (2.20–2.82) | < 0.001 | 1.83 (1.57–2.12) | < 0.001 |
< 4 | 3.21 (2.84–3.64) | < 0.001 | 2.11 (1.80–2.47) | < 0.001 |
< 5 | 4.56 (4.02–5.17) | < 0.001 | 2.59 (2.20–3.05) | < 0.001 |
≥ 5 | 7.37 (6.51–8.34) | < 0.001 | 3.39 (2.87–4.00) | < 0.001 |
Unknown | 4.46 (3.94–5.06) | < 0.001 | 2.73 (2.29–3.25) | < 0.001 |
Treatment | ||||
No/unknown | Reference | Reference | ||
Surgery | 0.163 (0.15–0.18) | < 0.001 | 0.33 (0.29–0.37) | < 0.001 |
Radiation | 0.441 (0.40–0.49) | < 0.001 | 0.53 (0.47–0.59) | < 0.001 |
Chemotherapy + XRT | 0.28 (0.26–0.30) | < 0.001 | 0.33 (0.30–0.36) | < 0.001 |
Surgery + XRT | 0.23 (0.21–0.25) | < 0.001 | 0.35 (0.32–0.39) | < 0.001 |
Triple therapy | 0.23 (0.21–0.25) | < 0.001 | 0.34 (0.31–0.38) | < 0.001 |
Others | 0.74 (0.66–0.83) | < 0.001 | 0.65 (0.57–0.75) | < 0.001 |
Grade | ||||
Well-differentiated | Reference | Reference | ||
Moderately differentiated | 1.28 (1.21–1.36) | < 0.001 | 1.08 (1.01–1.16) | 0.023 |
Poorly differentiated | 1.05 (0.99–1.12) | 0.130 | 0.86 (0.80–0.93) | < 0.001 |
Undifferentiated | 0.87 (0.69–1.11) | 0.260 | 0.69 (0.54–0.88) | 0.003 |
T classification | ||||
T1 | Reference | Reference | ||
T2 | 1.80 (1.70–1.92) | < 0.001 | 1.17 (1.06–1.30) | 0.002 |
T3 | 3.09 (2.89–3.30) | < 0.001 | 1.29 (1.15–1.45) | < 0.001 |
T4 | 4.48 (4.23–4.75) | < 0.001 | 1.94 (1.74–2.16) | < 0.001 |
Unknown | 2.18 (2.01–2.36) | < 0.001 | 0.85 (0.73–0.98) | 0.025 |
N classification | ||||
N0 | Reference | Reference | ||
N1 | 1.52 (1.43–1.60) | < 0.001 | 1.48 (1.39–1.58) | < 0.001 |
N2 | 1.63 (1.55–1.70) | < 0.001 | 1.56 (1.47–1.65) | < 0.001 |
N3 | 2.34 (2.14–2.57) | < 0.001 | 2.06 (1.84–2.31) | < 0.001 |
Unknown | 2.87 (2.46–3.35) | < 0.001 | 1.50 (1.26–1.79) | < 0.001 |
M classification | ||||
M0 | Reference | Reference | ||
M1 | 4.39 (4.05–4.76) | < 0.001 | 2.62 (2.36–2.90) | < 0.001 |
Unknown | 2.60 (2.11–3.22) | < 0.001 | 1.47 (1.12–1.93) | 0.006 |